These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9207471)

  • 21. Enhancement of retention and cytotoxicity of 2-chlorodeoxyadenosine in cultured human leukemic lymphoblasts by nitrobenzylthioinosine, an inhibitor of equilibrative nucleoside transport.
    Wright AM; Gati WP; Paterson AR
    Leukemia; 2000 Jan; 14(1):52-60. PubMed ID: 10637477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytosine arabinoside in the treatment of T-cell acute lymphoblastic leukemia.
    Wiley JS; Woodruff RK; Jamieson GP; Firkin FC; Sawyer WH
    Aust N Z J Med; 1987 Aug; 17(4):379-86. PubMed ID: 3501710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and evaluation of 5'-S-aminoethyl-N(6)- azidobenzyl-5'-thioadenosine biotin conjugate: a bifunctional photoaffinity probe for the es nucleoside transporter.
    Addo JK; Buolamwini JK
    Bioconjug Chem; 2004; 15(3):536-40. PubMed ID: 15149181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleoside transport in acute leukaemia and lymphoma: close relation to proliferative rate.
    Wiley JS; Snook MB; Jamieson GP
    Br J Haematol; 1989 Feb; 71(2):203-7. PubMed ID: 2923806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a small reporter molecule to determine cell-surface proteins by capillary electrophoresis and laser-induced fluorescence: use of 5-SAENTA-x8f for quantitation of the human equilibrative nucleoside transporter 1 protein.
    Li N; Cook L; Santos C; Cass CE; Mackey JR; Dovichi NJ
    Anal Chem; 2002 Jun; 74(11):2573-7. PubMed ID: 12069239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and flow cytometric evaluation of novel 1,2,3,4-tetrahydroisoquinoline conformationally constrained analogues of nitrobenzylmercaptopurine riboside (NBMPR) designed for probing its conformation when bound to the es nucleoside transporter.
    Zhu Z; Furr J; Buolamwini JK
    J Med Chem; 2003 Feb; 46(5):831-7. PubMed ID: 12593662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saturation of intracellular cytosine arabinoside triphosphate accumulation in human leukemic blast cells.
    Jamieson GP; Snook MB; Wiley JS
    Leuk Res; 1990; 14(5):475-9. PubMed ID: 2345470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleoside transport and cytosine arabinoside (araC) metabolism in human T lymphoblasts resistant to araC, thymidine and 6-methylmercaptopurine riboside.
    Young I; Young GJ; Wiley JS; van der Weyden MB
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1077-82. PubMed ID: 3877635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic analysis of ligand binding to the Ehrlich cell nucleoside transporter: pharmacological characterization of allosteric interactions with the [3H]nitrobenzylthioinosine binding site.
    Hammond JR
    Mol Pharmacol; 1991 Jun; 39(6):771-9. PubMed ID: 2051991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and reconstitution of the nucleoside transporter of CEM human leukemia cells.
    Crawford CR; Ng CY; Ullman B; Belt JA
    Biochim Biophys Acta; 1990 May; 1024(2):289-97. PubMed ID: 2112949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleoside transport in normal and neoplastic cells.
    Belt JA; Marina NM; Phelps DA; Crawford CR
    Adv Enzyme Regul; 1993; 33():235-52. PubMed ID: 8356910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
    Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
    Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L1210/B23.1 cells express equilibrative, inhibitor-sensitive nucleoside transport activity and lack two parental nucleoside transport activities.
    Vijayalakshmi D; Dagnino L; Belt JA; Gati WP; Cass CE; Paterson AR
    J Biol Chem; 1992 Aug; 267(24):16951-6. PubMed ID: 1512237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing therapy for acute myeloid leukemia based on differences in intracellular metabolism of cytosine arabinoside between leukemic blasts and normal mononuclear blood cells.
    Hiddemann W; Schleyer E; Unterhalt M; Kern W; Büchner T
    Ther Drug Monit; 1996 Aug; 18(4):341-9. PubMed ID: 8857548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity.
    Gourdeau H; Bibeau L; Ouellet F; Custeau D; Bernier L; Bowlin T
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):236-40. PubMed ID: 11320667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of inhibition of N-linked glycosylation by tunicamycin on nucleoside transport polypeptides of L1210 leukemia cells.
    Hogue DL; Hodgson KC; Cass CE
    Biochem Cell Biol; 1990 Jan; 68(1):199-209. PubMed ID: 2350487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.
    Rahn JJ; Kieller DM; Tyrrell DL; Gati WP
    Antimicrob Agents Chemother; 1997 May; 41(5):918-23. PubMed ID: 9145844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cells.
    Powell BL; White JC; Gregory BW; Brockschmidt JK; Rhinehardt-Clark A; Lyerly ES; Chorley HM; Capizzi RL
    Leukemia; 1991 Jul; 5(7):598-601. PubMed ID: 2072744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
    Xie XT; Jiang SY; Li BS; Yang LL
    Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line.
    Verschuur AC; Brinkman J; Van Gennip AH; Leen R; Vet RJ; Evers LM; Voûte PA; Van Kuilenburg AB
    Leuk Res; 2001 Oct; 25(10):891-900. PubMed ID: 11532523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.